As of August 28, 2026, Relmada Therapeutics, Inc. (RLMD) has a DilutionWatch DilutionScore of 58/100, rated HIGH dilution risk. Relmada Therapeutics, Inc. has a market capitalization of $756.26M, 106.67M shares outstanding, 106 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $100.00M, 1.26M outstanding warrants.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 9%
💰 Capital Raise
model 18%
• Active ATM program with $100M remaining capacity
Market Data
Market Cap$756.26M
Shares Outstanding106.67M
Float7.72M
Cash$217.73M
Debt$110.2K
Short InterestN/A
Institutional Holdings
QoQ: ↑ 100.1% shares (2026Q1 vs prior)
106 institutional holders · 102.62M shares
#1
JANUS HENDERSON GROUP PLC
22.13M shares
#2
Squadron Capital Management LLC
8.47M shares
#3
Spruce Street Capital LP
6.26M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest13.56M
Days to Cover7.8
% of Float175.7%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2025-11-05
xbrl
XBRL CONVERTIBLE
2018-10-31
8-K
8K EVENT
2026-03-09
424B5
ATM
2026-01-30
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual RLMD Dilution Snapshot
Relmada Therapeutics, Inc. (RLMD) has a DilutionScore of 58/100, rated High dilution risk. Score date: August 28, 2026.
- Stored ATM program remaining capacity: $100.0M.
- Stored outstanding warrants: 1.3M.
- Recent SEC activity tracked for RLMD: 8-K on 2026-03-09; 424B5 on 2026-01-30; xbrl on 2025-11-05.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track RLMD Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RLMD — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for RLMD
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.